Dr. George Thomas is a professor of pathology at the Knight Cancer Institute, Oregon Health & Science University in Portland, Oregon. He is also associate medical director of the Knight Diagnostics Laboratory. His clinical area of expertise is in precision oncology of prostate and kidney cancers. He directs a translational research program that studies treatment induced metabolic reprogramming in these cancers, with the goal of developing new combination therapies. Dr. Thomas received his MD from the Royal College of Surgeons in Ireland, and did his pathology residency and research fellowship at the University of California, Los Angeles.